Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2).
D000328:Adult; D000368:Aged; D011464:Epoprostenol / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007259:Infrared Rays; D007263:Infusions, Parenteral; D008297:Male; D008875:Middle Aged; D011453:Prostaglandins / Q000627:therapeutic use*; D011874:Radiometry; D011928:Raynaud Disease / Q000188:drug therapy* / Q000503:physiopathology; D013817:Thermography; D013997:Time Factors
D011453:Prostaglandins; D011464:Epoprostenol